Globus Medical, Inc.GMEDNYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank97
3Y CAGR+61.6%
5Y CAGR+69.5%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+61.6%/yr
vs +342.3%/yr prior
5Y CAGR
+69.5%/yr
Recent deceleration
Acceleration
-280.7pp
Decelerating
Percentile
P97
Near historical high
vs 5Y Ago
14x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 45.50% |
| Q3 2025 | 3.29% |
| Q2 2025 | 25.05% |
| Q1 2025 | -4.21% |
| Q4 2024 | 5.29% |
| Q3 2024 | 0.54% |
| Q2 2024 | -3.71% |
| Q1 2024 | 1.62% |
| Q4 2023 | 56.66% |
| Q3 2023 | 30.10% |
| Q2 2023 | -1.92% |
| Q1 2023 | 3.68% |
| Q4 2022 | 10.79% |
| Q3 2022 | -0.13% |
| Q2 2022 | 5.93% |
| Q1 2022 | -5.45% |
| Q4 2021 | 10.49% |
| Q3 2021 | -10.08% |
| Q2 2021 | 9.56% |
| Q1 2021 | 6.35% |
| Q4 2020 | 3.25% |
| Q3 2020 | 11.41% |
| Q2 2020 | -14.45% |
| Q1 2020 | 1.52% |
| Q4 2019 | 4.16% |
| Q3 2019 | 0.09% |
| Q2 2019 | 3.03% |
| Q1 2019 | 2.56% |
| Q4 2018 | 11.33% |
| Q3 2018 | -2.59% |
| Q2 2018 | 1.89% |
| Q1 2018 | 3.75% |
| Q4 2017 | 15.14% |
| Q3 2017 | -1.67% |
| Q2 2017 | -3.91% |
| Q1 2017 | 10.22% |
| Q4 2016 | 12.23% |
| Q3 2016 | 3.43% |
| Q2 2016 | -3.96% |
| Q1 2016 | 2.21% |